Adverse events50

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 50

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Diarrhoea	Gastrointestinal disorders	Rozanolixizumab (Newly Treated)	1	11	2
other	Diarrhoea	Gastrointestinal disorders	Rozanolixizumab (Previously Treated)	1	10	1
other	Constipation	Gastrointestinal disorders	Rozanolixizumab (Newly Treated)	0	11	0
other	Constipation	Gastrointestinal disorders	Rozanolixizumab (Previously Treated)	2	10	2
other	Fatigue	General disorders	Rozanolixizumab (Newly Treated)	3	11	3
other	Fatigue	General disorders	Rozanolixizumab (Previously Treated)	3	10	4
other	Pyrexia	General disorders	Rozanolixizumab (Newly Treated)	2	11	2
other	Pyrexia	General disorders	Rozanolixizumab (Previously Treated)	0	10	0
other	Peripheral swelling	General disorders	Rozanolixizumab (Newly Treated)	1	11	1
other	Peripheral swelling	General disorders	Rozanolixizumab (Previously Treated)	1	10	1
other	Influenza	Infections and infestations	Rozanolixizumab (Newly Treated)	2	11	2
other	Influenza	Infections and infestations	Rozanolixizumab (Previously Treated)	0	10	0
other	Nasopharyngitis	Infections and infestations	Rozanolixizumab (Newly Treated)	2	11	2
other	Nasopharyngitis	Infections and infestations	Rozanolixizumab (Previously Treated)	2	10	2
other	Upper respiratory tract infection	Infections and infestations	Rozanolixizumab (Newly Treated)	2	11	2
other	Upper respiratory tract infection	Infections and infestations	Rozanolixizumab (Previously Treated)	0	10	0
other	Urinary tract infection	Infections and infestations	Rozanolixizumab (Newly Treated)	2	11	2
other	Urinary tract infection	Infections and infestations	Rozanolixizumab (Previously Treated)	0	10	0
other	Muscle strain	Injury, poisoning and procedural complications	Rozanolixizumab (Newly Treated)	1	11	1
other	Muscle strain	Injury, poisoning and procedural complications	Rozanolixizumab (Previously Treated)	2	10	2

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04051944/events

API reference For AI assistants

Adverse events50

Sources 3

Read this list from software.